Left Ventricular Assist Device Infections and the Potential Role for Dalbavancin: A Case Report

被引:14
作者
Howard-Anderson, Jessica [1 ]
Pouch, Stephanie M. [1 ]
Sexton, Mary Elizabeth [1 ]
Mehta, Aneesh K. [1 ]
Smith, Andrew L. [2 ]
Lyon, George M., III [1 ]
Friedman-Moraco, Rachel [1 ]
机构
[1] Emory Univ, Sch Med, Dept Med, Div Infect Dis, 49 Jesse Hill Jr Dr, Atlanta, GA 30303 USA
[2] Emory Univ, Sch Med, Dept Med, Div Cardiol, Atlanta, GA USA
基金
美国国家卫生研究院;
关键词
dalbavancin; left ventricular assist devices; Staphylococcus aureus; SKIN;
D O I
10.1093/ofid/ofz235
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Left ventricular assist device infections (LVADIs) are common but challenging to treat, often requiring prolonged courses of intravenous antibiotics. Dalbavancin could have a role in treating patients with chronic LVADIs given its less frequent dosing requirements. Here, we illustrate a case in which dalbavancin was used as suppressive therapy for an LVADI for greater than 7 months.
引用
收藏
页数:3
相关论文
共 15 条
[1]   Newer glycopeptide antibiotics for treatment of complicated skin and soft tissue infections: systematic review, network meta-analysis and cost analysis [J].
Agarwal, R. ;
Bartsch, S. M. ;
Kelly, B. J. ;
Prewitt, M. ;
Liu, Y. ;
Chen, Y. ;
Umscheid, C. A. .
CLINICAL MICROBIOLOGY AND INFECTION, 2018, 24 (04) :361-368
[2]   Dalbavancin for the management of gram-positive osteomyelitis: Effectiveness and potential utility [J].
Almangour, Thamer A. ;
Perry, Gregory K. ;
Terriff, Colleen M. ;
Alhifany, Abdullah A. ;
Kaye, Keith S. .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2019, 93 (03) :213-218
[3]   Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection [J].
Boucher, Helen W. ;
Wilcox, Mark ;
Talbot, George H. ;
Puttagunta, Sailaja ;
Das, Anita F. ;
Dunne, Michael W. .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (23) :2169-2179
[4]   Dalbavancin in the treatment of different gram-positive infections: a real-life experience [J].
Bouza, Emilio ;
Valerio, Maricela ;
Soriano, Alex ;
Morata, Laura ;
Garcia Carus, Enrique ;
Rodriguez-Gonzalez, Carmen ;
Hidalgo-Tenorio, Ma Carmen ;
Plata, Antonio ;
Munoz, Patricia ;
Vena, Antonio .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2018, 51 (04) :571-577
[5]   Mutant selection window hypothesis updated [J].
Drlica, Karl ;
Zhao, Xilin .
CLINICAL INFECTIOUS DISEASES, 2007, 44 (05) :681-688
[6]   A Randomized Clinical Trial of Single-Dose Versus Weekly Dalbavancin for Treatment of Acute Bacterial Skin and Skin Structure Infection [J].
Dunne, Michael W. ;
Puttagunta, Sailaja ;
Giordano, Philip ;
Krievins, Dainis ;
Zelasky, Michael ;
Baldassarre, James .
CLINICAL INFECTIOUS DISEASES, 2016, 62 (05) :545-551
[7]   Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies [J].
Dunne, Michael W. ;
Talbot, George H. ;
Boucher, Helen W. ;
Wilcox, Mark ;
Puttagunta, Sailaja .
DRUG SAFETY, 2016, 39 (02) :147-157
[8]   Extended-Duration Dosing and Distribution of Dalbavancin into Bone and Articular Tissue [J].
Dunne, Michael W. ;
Puttagunta, Sailaja ;
Sprenger, Craig R. ;
Rubino, Chris ;
Van Wart, Scott ;
Baldassarre, James .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2015, 59 (04) :1849-1855
[9]   Emergence of a dalbavancin induced glycopeptide/lipoglycopeptide non-susceptible Staphylococcus aureus during treatment of a cardiac device-related endocarditis [J].
Kussmann, Manuel ;
Karer, Matthias ;
Obermueller, Markus ;
Schmidt, Katy ;
Barousch, Wolfgang ;
Moser, Doris ;
Nehr, Marion ;
Ramharter, Michael ;
Poeppl, Wolfgang ;
Makristathis, Athanasios ;
Winkler, Stefan ;
Thalhammer, Florian ;
Burgmann, Heinz ;
Lagler, Heimo .
EMERGING MICROBES & INFECTIONS, 2018, 7
[10]   Increasing Frequency of Left Ventricular Assist Device Exchanges in the United States [J].
McCarthy, Fenton H. ;
Kobrin, Dale ;
Rame, J. Eduardo ;
Groeneveld, Peter W. ;
McDermott, Katherine M. ;
Atluri, Pavan ;
Acker, Michael A. ;
Desai, Nimesh D. .
ANNALS OF THORACIC SURGERY, 2015, 100 (05) :1660-1665